Mesoblast Limited (MESO)
Preliminary Final Report including Appendix 4E
Preliminary Final Report including Appendix 4E
Privia Health ACOs Delivered $233+ Million in Total Savings in the 2024 Performance Year of Medicare Shared Savings Program, a 32% Year-over-Year Increase
Sharps Technology, Inc. Closes Over $400 Million Private Placement, Launching Solana Digital Asset Treasury Strategy
New Form 8-K - Mitesco, Inc. Filed: 2025-08-28 AccNo: 0001185185-25-001092 Size: 235 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 5.01: Changes in Control of Registrant Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: …
Vanda Pharmaceuticals Announces Participation at September 2025 Investor Conferences